AbbVie (ABBV) reported Q1 adjusted earnings Friday of $2.46 per diluted share, up from $2.31 a year earlier.
Analysts polled by FactSet expected $2.38.
Net revenue for the quarter ended March 31 was $13.34 billion, up from $12.31 billion a year earlier.
Analysts surveyed by FactSet expected $12.93 billion.
For full-year 2025, the company said it now expects adjusted diluted earnings of $12.09 to $12.29, compared with its previous guidance of $11.99 to $12.19.
Analysts surveyed by FactSet expect $12.16.
Shares of the company were up more than 2% in recent premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。